中文

晨光生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-25
ItemAmountY/Y
Revenue¥1.63B-5.1%
Gross profit¥0.22B
Operating income¥0.11B
Net income¥0.10B-11.5%
Gross margin13.7%Net margin 6.0%
Revenue Q/Q+7.8%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥1.41B86.3%
R&D¥0.03B2.0%
SG&A¥0.05B3.0%
Tax & other¥0.02B0.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

晓程科技节能环境和顺电气沃森生物盈康生命宋城演艺南方泵业汤臣倍健*ST香雪天舟文化睿智医药世纪瑞尔

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies